These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 10234725)

  • 61. Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.
    Wilde MI; Markham A
    Drugs; 1997 Dec; 54(6):903-24. PubMed ID: 9421696
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Heparin-induced thrombocytopenia: a frequent complication after cardiac surgery.
    Pouplard C; Regina S; May MA; Gruel Y
    Arch Mal Coeur Vaiss; 2007; 100(6-7):563-8. PubMed ID: 17893639
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients.
    Wester JP; Haas FJ; Biesma DH; Leusink JA; Veth G
    Intensive Care Med; 2004 Oct; 30(10):1927-34. PubMed ID: 15156309
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Heparin-induced thrombocytopenia: laboratory diagnosis and management.
    Elalamy I; Lecrubier C; Horellou MH; Conard J; Samama MM
    Ann Med; 2000 Dec; 32 Suppl 1():60-7. PubMed ID: 11209984
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Diagnosis and development of heparin-induced thrombocytopenia. Biological and clinical aspects].
    Elalamy I; Page Y; Viallon A; Tardy B; Conard J; Helft G
    Rev Mal Respir; 1999 Nov; 16(5 Pt 2):961-74. PubMed ID: 10907445
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of heparin-induced thrombocytopenia.
    Dager WE; White RH
    Ann Pharmacother; 2002 Mar; 36(3):489-503. PubMed ID: 11895064
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Heparin-induced thrombocytopenia in France, 1980-1998.
    Nguyen P; de Maistre E; Cornillet-Lefebvre P; Regnault V; Lecompte T
    Semin Thromb Hemost; 1999; 25 Suppl 1():9-15. PubMed ID: 10357146
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Sinus vein thrombosis. A rare complication of heparin-induced thrombocytopenia type II].
    Merz S; Fehr R; Gülke C
    Anaesthesist; 2004 Jun; 53(6):551-4. PubMed ID: 15146282
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Delayed-type hypersensitivity to subcutaneous heparin with tolerance of i.v. administration.
    Liew G; Campbell C; Thursby P
    ANZ J Surg; 2004 Nov; 74(11):1020-1. PubMed ID: 15550103
    [No Abstract]   [Full Text] [Related]  

  • 70. Anticoagulation with recombinant hirudin and danaparoid sodium in pediatric patients.
    Severin T; Zieger B; Sutor AH
    Semin Thromb Hemost; 2002 Oct; 28(5):447-54. PubMed ID: 12420240
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Current recommendations for diagnosis and therapy of heparin-induced thrombocytopenia].
    Hinz P; Lubenow N; Eckernkamp A; Geinacher A
    Unfallchirurg; 2002 Sep; 105(9):845-50. PubMed ID: 12232745
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy.
    Hassell K
    Chest; 2005 Feb; 127(2 Suppl):1S-8S. PubMed ID: 15706025
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transition to an oral anticoagulant in patients with heparin-induced thrombocytopenia.
    Bartholomew JR
    Chest; 2005 Feb; 127(2 Suppl):27S-34S. PubMed ID: 15706028
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Heparin-induced thrombocytopenia and cardiovascular diseases.
    Das P; Ziada K; Steinhubl SR; Moliterno DJ; Hamdalla H; Jozic J; Mukherjee D
    Am Heart J; 2006 Jul; 152(1):19-26. PubMed ID: 16824828
    [No Abstract]   [Full Text] [Related]  

  • 75. Thromboembolic complications in a patient with heparin-induced thrombocytopenia (HIT) showing cross-reactivity to a low molecular weight heparin-treatment with Org 10172 (Lomoparan).
    Muhm M; Claeys L; Huk I; Koppensteiner R; Kyrle PA; Minar E; Stümpflen A; Ehringer H; Polterauer P
    Wien Klin Wochenschr; 1997 Feb; 109(4):128-31. PubMed ID: 9076930
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HIT/HITT and alternative anticoagulation: current concepts.
    Lakshmanan S; Saha B; Rittoo D
    Br J Anaesth; 2003 Sep; 91(3):445; author reply 445-6. PubMed ID: 12966934
    [No Abstract]   [Full Text] [Related]  

  • 77. Failure of Orgaran therapy in a patient with a previous heparin-induced thrombocytopenia syndrome.
    Tardy/Poncet B; Mahul P; Beraud AM; Favre JP; Tardy B; Guyotat D
    Br J Haematol; 1995 Aug; 90(4):969-70. PubMed ID: 7669684
    [No Abstract]   [Full Text] [Related]  

  • 78. The use of danaparoid to manage coagulopathy in a neurosurgical patient with heparin-induced thrombocytopenia type II and intracerebral haemorrhage.
    Hertle DN; Hähnel S; Richter GM; Unterberg A; Sakowitz OW; Kiening KL
    Br J Neurosurg; 2011 Feb; 25(1):117-9. PubMed ID: 20707682
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Evaluation and management of drug-induced thrombocytopenia in the acutely ill patient.
    Wazny LD; Ariano RE
    Pharmacotherapy; 2000 Mar; 20(3):292-307. PubMed ID: 10730685
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Heparin as a cause of thrombus progression. Heparin-associated thrombocytopenia is an important differential diagnosis in paediatric patients even with normal platelet counts.
    Klement D; Rammos S; v Kries R; Kirschke W; Kniemeyer HW; Greinacher A
    Eur J Pediatr; 1996 Jan; 155(1):11-4. PubMed ID: 8750802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.